Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy

ABSTRACT: Background Up to 88% of cocaine is tainted with levamisole, an anthelmintic withdrawn from the market due to toxicity. Since 2010 levamisole-adulterated cocaine induced vasculopathy (LACIV) patients, characterised by retiform purpura, ear necrosis, multisystemic compromise and positivity f...

Full description

Autores:
Muñoz Vahos, Carlos Horacio
Herrera Uribe, Sebastián
Arbeláez Cortés, Álvaro
Jaramillo Arroyave, Daniel
González Naranjo, Luis Alonso
Vásquez Duque, Gloria María
Restrepo Escobar, Mauricio
Correa Londoño, Luis Alfonso
Hernández Zapata, Johanna
Vanegas García, Adriana Lucía
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/25991
Acceso en línea:
http://hdl.handle.net/10495/25991
Palabra clave:
Levamisol
Levamisole
Cocaína
Cocaine
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc/2.5/co/
id UDEA2_6af3b0b6e0ea21897a022b85ad5acd49
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/25991
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
title  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
spellingShingle  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
Levamisol
Levamisole
Cocaína
Cocaine
title_short  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
title_full  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
title_fullStr  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
title_full_unstemmed  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
title_sort  Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathy
dc.creator.fl_str_mv Muñoz Vahos, Carlos Horacio
Herrera Uribe, Sebastián
Arbeláez Cortés, Álvaro
Jaramillo Arroyave, Daniel
González Naranjo, Luis Alonso
Vásquez Duque, Gloria María
Restrepo Escobar, Mauricio
Correa Londoño, Luis Alfonso
Hernández Zapata, Johanna
Vanegas García, Adriana Lucía
dc.contributor.author.none.fl_str_mv Muñoz Vahos, Carlos Horacio
Herrera Uribe, Sebastián
Arbeláez Cortés, Álvaro
Jaramillo Arroyave, Daniel
González Naranjo, Luis Alonso
Vásquez Duque, Gloria María
Restrepo Escobar, Mauricio
Correa Londoño, Luis Alfonso
Hernández Zapata, Johanna
Vanegas García, Adriana Lucía
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Reumatología Universidad de Antioquia -GRUA-
Centro de de Investigaciones Dermatológicas
dc.subject.decs.none.fl_str_mv Levamisol
Levamisole
Cocaína
Cocaine
topic Levamisol
Levamisole
Cocaína
Cocaine
description ABSTRACT: Background Up to 88% of cocaine is tainted with levamisole, an anthelmintic withdrawn from the market due to toxicity. Since 2010 levamisole-adulterated cocaine induced vasculopathy (LACIV) patients, characterised by retiform purpura, ear necrosis, multisystemic compromise and positivity for multiple autoantibodies, have been reported. Knowing the pattern and the severity of skin involvement is essential in the approach of these patients. Objectives To describe the cutaneous manifestations of patients with LACIV and to propose a classification of skin involvement. Methods We describe the skin compromise of 30 patients with LACIV evaluated between December 2010 and May 2017. Based on this series and the review of the literature, we propose a classification according to the distribution and severity of the lesions. Results All patients were mestizo, median age of 31 (IQR 27–38), male:female ratio 5:1, time from symptoms to diagnosis 12 months (IQR 6–24). The most frequent clinical manifestations were skin lesions: ear necrosis (73%) and retiform purpura (83%) affecting the extensor part of the limbs, buttocks, face, and abdomen; sparing the scalp, palms and soles. Retiform purpura was classified in four grades according to distribution and severity (image). Skin biopsies revealed leukocytoclastic vasculitis (24%), pseudo-vasculitis (19%), thrombotic vasculopathy with leukocytoclastic vasculitis (19%), thrombotic vasculopathy with pseudo-vasculitis (19%), and pyoderma gangrenosum with vasculopathy (5%).
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2022-02-12T16:26:46Z
dc.date.available.none.fl_str_mv 2022-02-12T16:26:46Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Muñoz-Vahos C, Herrera-Uribe S, Arbeláez-Cortés Á, et alFRI0474 Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyAnnals of the Rheumatic Diseases 2018;77:765.
dc.identifier.issn.none.fl_str_mv 0003-4967
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/25991
dc.identifier.doi.none.fl_str_mv 10.1136/annrheumdis-2018-eular.2145
dc.identifier.eissn.none.fl_str_mv 1468-2060
identifier_str_mv Muñoz-Vahos C, Herrera-Uribe S, Arbeláez-Cortés Á, et alFRI0474 Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyAnnals of the Rheumatic Diseases 2018;77:765.
0003-4967
10.1136/annrheumdis-2018-eular.2145
1468-2060
url http://hdl.handle.net/10495/25991
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Ann. Rheum. Dis.
dc.relation.citationendpage.spa.fl_str_mv 765
dc.relation.citationstartpage.spa.fl_str_mv 765
dc.relation.citationvolume.spa.fl_str_mv 77
dc.relation.ispartofjournal.spa.fl_str_mv Annals of the Rheumatic Diseases
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/2.5/co/
https://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 1
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv BMJ Publishing Group
dc.publisher.place.spa.fl_str_mv Londres, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/bfbd565d-4810-45e6-9ce6-579fd7f93c40/download
https://bibliotecadigital.udea.edu.co/bitstreams/aadeff01-2a9e-49e2-bf5f-4d8998a9e613/download
https://bibliotecadigital.udea.edu.co/bitstreams/6972ab14-5176-420b-ad65-573bcf73c218/download
https://bibliotecadigital.udea.edu.co/bitstreams/4504a8c8-a4b8-4b21-b780-340060afb9ff/download
https://bibliotecadigital.udea.edu.co/bitstreams/2765c1b9-961d-4eab-8bf5-a26782a84be9/download
bitstream.checksum.fl_str_mv ba3c2d2df77880e2f8e6ddb800c69e16
c0c92b0ffc8b7d22d9cf56754a416a76
8a4605be74aa9ea9d79846c1fba20a33
e38c335be2c8e21a7ca798966ec8210d
75a44971c726c7acb07f189d343e71ca
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052351451824128
spelling Muñoz Vahos, Carlos HoracioHerrera Uribe, SebastiánArbeláez Cortés, ÁlvaroJaramillo Arroyave, DanielGonzález Naranjo, Luis AlonsoVásquez Duque, Gloria MaríaRestrepo Escobar, MauricioCorrea Londoño, Luis AlfonsoHernández Zapata, JohannaVanegas García, Adriana LucíaGrupo de Reumatología Universidad de Antioquia -GRUA-Centro de de Investigaciones Dermatológicas2022-02-12T16:26:46Z2022-02-12T16:26:46Z2018Muñoz-Vahos C, Herrera-Uribe S, Arbeláez-Cortés Á, et alFRI0474 Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyAnnals of the Rheumatic Diseases 2018;77:765.0003-4967http://hdl.handle.net/10495/2599110.1136/annrheumdis-2018-eular.21451468-2060ABSTRACT: Background Up to 88% of cocaine is tainted with levamisole, an anthelmintic withdrawn from the market due to toxicity. Since 2010 levamisole-adulterated cocaine induced vasculopathy (LACIV) patients, characterised by retiform purpura, ear necrosis, multisystemic compromise and positivity for multiple autoantibodies, have been reported. Knowing the pattern and the severity of skin involvement is essential in the approach of these patients. Objectives To describe the cutaneous manifestations of patients with LACIV and to propose a classification of skin involvement. Methods We describe the skin compromise of 30 patients with LACIV evaluated between December 2010 and May 2017. Based on this series and the review of the literature, we propose a classification according to the distribution and severity of the lesions. Results All patients were mestizo, median age of 31 (IQR 27–38), male:female ratio 5:1, time from symptoms to diagnosis 12 months (IQR 6–24). The most frequent clinical manifestations were skin lesions: ear necrosis (73%) and retiform purpura (83%) affecting the extensor part of the limbs, buttocks, face, and abdomen; sparing the scalp, palms and soles. Retiform purpura was classified in four grades according to distribution and severity (image). Skin biopsies revealed leukocytoclastic vasculitis (24%), pseudo-vasculitis (19%), thrombotic vasculopathy with leukocytoclastic vasculitis (19%), thrombotic vasculopathy with pseudo-vasculitis (19%), and pyoderma gangrenosum with vasculopathy (5%).COL0010959COL01307331application/pdfengBMJ Publishing GroupLondres, Inglaterrahttp://creativecommons.org/licenses/by-nc/2.5/co/https://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2 Classification of skin involvement in levamisole-adulterated cocaine induced vasculopathyArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionLevamisolLevamisoleCocaínaCocaineAnn. Rheum. Dis.76576577Annals of the Rheumatic DiseasesPublicationORIGINALMuñozCarlos_2018_.pdfMuñozCarlos_2018_.pdfArtículo de investigaciónapplication/pdf489507https://bibliotecadigital.udea.edu.co/bitstreams/bfbd565d-4810-45e6-9ce6-579fd7f93c40/downloadba3c2d2df77880e2f8e6ddb800c69e16MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8933https://bibliotecadigital.udea.edu.co/bitstreams/aadeff01-2a9e-49e2-bf5f-4d8998a9e613/downloadc0c92b0ffc8b7d22d9cf56754a416a76MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/6972ab14-5176-420b-ad65-573bcf73c218/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTMuñozCarlos_2018_.pdf.txtMuñozCarlos_2018_.pdf.txtExtracted texttext/plain6933https://bibliotecadigital.udea.edu.co/bitstreams/4504a8c8-a4b8-4b21-b780-340060afb9ff/downloade38c335be2c8e21a7ca798966ec8210dMD54falseAnonymousREADTHUMBNAILMuñozCarlos_2018_.pdf.jpgMuñozCarlos_2018_.pdf.jpgGenerated Thumbnailimage/jpeg16018https://bibliotecadigital.udea.edu.co/bitstreams/2765c1b9-961d-4eab-8bf5-a26782a84be9/download75a44971c726c7acb07f189d343e71caMD55falseAnonymousREAD10495/25991oai:bibliotecadigital.udea.edu.co:10495/259912025-03-26 20:59:15.891http://creativecommons.org/licenses/by-nc/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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